ViewRay
ViewRay Systems, Inc. is a medical technology company based in Cleveland, Ohio, known for its MRIdian A3i MRI-guided radiation therapy system.
Last updated September 1, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
ViewRay Systems, Inc. is a medical technology company based in Cleveland, Ohio. The company offers the MRIdian A3i, an MRI-guided radiation therapy system. The system is described as the first MR-guided radiotherapy system with peer-reviewed evidence demonstrating reduced side effects and extended survival. The company's headquarters is located at 2 Thermo Fisher Way, Oakwood Village, Ohio 44146.
History
ViewRay Systems, Inc. is a medical technology company based in Cleveland, Ohio. The company offers the MRIdian A3i, an MRI-guided radiation therapy system. The system is described as the first MR-guided radiotherapy system with peer-reviewed evidence demonstrating reduced side effects and extended survival. The company's headquarters is located at 2 Thermo Fisher Way, Oakwood Village, Ohio 44146.
Products and positioning
MRIdian A3i
MRI-guided radiation therapy system
Recent events
Reported
ViewRay prices public stock offering[4]
ViewRay announced the pricing of an underwritten public offering of 12.5 million common shares at $5.60 per share, for gross proceeds of $70 million before expenses. The offering was expected to close on or about November 19, 2021, subject to customary conditions.
Reported
Elekta and ViewRay announced MR-guided radiation therapy collaboration[5]
Elekta announced that it had signed a non-binding memorandum of understanding with ViewRay to advance knowledge and application of MR-guided radiation therapy. The companies said the collaboration was subject to definitive documentation.
Reported
ViewRay prices public stock offering[6]
ViewRay announced pricing for an underwritten public offering of 41,550,000 shares at $3.13 per share, for gross proceeds of approximately $130.1 million before expenses.
Reported
ViewRay and Medtronic announced a clinical collaboration memorandum[7]
ViewRay announced that it signed a non-binding memorandum of understanding with Medtronic to enter into a clinical collaboration, including exploring clinical benefits of the MRIdian MR-guided radiation therapy system. Medtronic committed to invest in a minority interest in ViewRay, subject to a commitment agreement.
Reported
ViewRay and Elekta announced a collaboration memorandum[7]
ViewRay announced that it signed a non-binding memorandum of understanding with Elekta for collaboration to advance knowledge and use of MR-guided radiation therapy. The collaboration is subject to execution of definitive documentation.
Sources8 sources
- 1ViewRay Systems, Inc. - Visibly Betterviewraysystems.com
- 2Contact Us - ViewRay Systems, Inc.viewraysystems.com
- 3ViewRaywikidata.org
- 4ViewRay为公开发行股票定价prnewswire.com
- 5Elekta与ViewRay宣布开展磁共振引导放射治疗合作itnonline.com
- 6ViewRay公布公开发行股票定价prnewswire.com
- 7ViewRay 与美敦力宣布临床合作谅解备忘录prnewswire.com
- 8ViewRay Announces Pricing of Public Offering of Common Stockprnewswire.com
Cite this profile: Cite the canonical profile. /brand-wiki/viewray · Editorial policy · How profiles are compiled